{
  "id": 10137146,
  "title": "Twist Bioscience CEO Emily Leproust sells $279,183 in stock",
  "url": "https://urgent.news/2026/09/27/twist-bioscience-ceo-emily-leproust-sells-279-183-in-stock",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-09-27T04:16:04.000Z",
  "source": {
    "name": "Investing.com",
    "slug": "investing-com",
    "url": "https://www.investing.com/news/insider-trading-news/twist-bioscience-ceo-emily-leproust-sells-279183-in-stock-93CH-4918790"
  },
  "original_language": "en",
  "account": "Twist Bioscience CEO Emily Leproust sold 1,687 shares of the company's common stock on September 21, 2026, for a total of $279,183. The shares were sold at $165.491 each and the transaction was executed to cover tax withholding obligations related to the vesting of Restricted Stock Units. The sale of these shares occurred as TWST stock has increased by 579% over the past year, currently trading near its 52-week high of $186.20. According to InvestingPro analysis, the stock appears to be overvalued at its current level, placing it among companies on the Most Overvalued list.",
  "summary": null,
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 2,
    "also_reported_by": [
      {
        "outlet": "Investing.com",
        "title": "Twist Bioscience SVP Paula Green sells $48,654 in common stock",
        "url": "https://urgent.news/2026/09/27/twist-bioscience-svp-paula-green-sells-48-654-in-common-stock",
        "published": "2026-09-27T04:16:00.000Z"
      }
    ]
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}